Laser-Assisted Drug Delivery Is Effective in Alopecia but Lacks Comparison With Existing Treatments
April 10th 2024Studies show that laser-assisted drug delivery (LADD) improves hair growth in patients with alopecia. However, researchers are still looking at the best ways to compare LADD's effectiveness against other methods like microneedling.
Read More
Combination Therapies Optimize Hair Regrowth in Pediatric Patients With AA
April 4th 2024Corticosteroids are the most common treatment for pediatric patients with alopecia areata (AA), but promising newer options like JAK inhibitors are emerging. This review highlights the importance of personalized treatment plans and maximizing response through combination therapies.
Read More
Light Therapy Clothing Shows Potential for Mild Psoriasis, PMLE, AA Treatment
March 29th 2024Red and near-infrared–emitting fabric clothing may improve symptoms of mild psoriasis, polymorphous light eruption (PMLE), and alopecia areata (AA), but further research with larger groups is needed due to limitations in the pilot study design.
Read More
Alopecia Areata Impacts Patient Perception, Quality of Life
March 27th 2024Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Read More
Tofacitinib Effective for AA, Earlier Intervention Improves Outcomes
March 20th 2024Research suggests tofacitinib effectively treats alopecia areata (AA), particularly when used early for severe cases. This offers promising evidence for doctors to consider when making treatment plans for patients.
Read More
Deuruxolitinib Demonstrates Efficacy, Tolerability in Patients With Moderate to Severe AA
March 14th 2024Posters suggest deuruxolitinib, a medication targeting specific cellular pathways, effectively promotes hair regrowth in patients with moderate to severe alopecia areata (AA) and results in minimal adverse events.
Read More
Experts Measure AA Severity With Key Factors, Reach Consensus on Treatment Decisions
February 29th 2024An expert survey using the eDelphi method pinpointed disease duration, treatment response, and mental health as crucial factors in a new multidimensional tool known as Alopecia Areata Severity and Morbidity Index (ASAMI), underlining the importance of personalized treatments for future research incorporating patient perspectives.
Read More
Study Finds AA Associated With Connective Tissue, Ocular Diseases and Vitamin D Deficiency
February 9th 2024Meta-analysis results identify high and low associations of various comorbidities like vitamin D deficiencies, ocular diseases, among others in patients with alopecia areata (AA), to promptly manage and improve treatment outcomes.
Read More
Study Finds Significant Hair Regrowth in Patients With Patchy AA Following Baricitinib Treatment
February 7th 2024Baricitinib was found to be an effective treatment for patchy alopecia areata (AA), in a retrospective study, with most patients experiencing hair regrowth after 4 to 16 weeks of treatment.
Read More
Tofacitinib as AA Treatment Has High Drug Survival Rates, Manageable Side Effects
January 25th 2024A study from China found that tofacitinib was an effective treatment for alopecia areata (AA), with most patients achieving complete or partial hair regrowth and experiencing tolerable side effects.
Read More
Topical Corticosteroids: The Preferred First-Line Treatment for Pediatric Alopecia Areata
January 20th 2024A survey of pediatric dermatologists revealed that topical corticosteroids are the most common first-line treatment for children with alopecia areata, regardless of age or hair loss severity.
Read More
Evaluating Hair Camouflage as a Tool for Black Women With Alopecia: A Critical Review
January 18th 2024Black women with alopecia often struggle between concealing their hair loss and protecting their fragile scalps, all while seeking to express their cultural identity and build self-confidence.
Read More
Shared Decision-Making Linked With Improved Treatment Satisfaction in Alopecia Areata
September 8th 2022Patients with alopecia areata were less likely to report decisional regret regarding treatment when dermatologists incorporated shared decision-making, with prescription of Janus kinase (JAK) inhibitors associated with the lowest decisional regret.
Read More